Prosight Management, LP - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 48 filers reported holding MILLENDO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$370,000
-56.7%
52,051
-29.5%
0.20%
-52.4%
Q2 2019$854,000
-79.0%
73,868
-72.7%
0.43%
-75.7%
Q1 2019$4,061,000
+99.0%
270,762
+5.5%
1.78%
+68.6%
Q4 2018$2,041,000256,7391.05%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$16,145,0004.14%
GREAT POINT PARTNERS LLC 1,288,093$14,891,000,0001.65%
NEA Management Company, LLC 1,766,779$20,424,0001.43%
Bpifrance SA 1,078,670$12,469,0001.34%
ADAMS STREET PARTNERS LLC 409,146$4,730,0000.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$2,056,0000.76%
Prosight Management, LP 73,868$854,0000.43%
Samsara BioCapital, LLC 45,101$521,0000.34%
AWM Investment Company, Inc. 77,629$897,0000.17%
GMT CAPITAL CORP 53,419$618,0000.02%
View complete list of MILLENDO THERAPEUTICS INC shareholders